Phillip Pang is VP at Vir Biotechnology, Inc. (VIR). They have made 37 open-market trades across 1 company since 2020, most recently 2024-02-22.
CIK 0001787370
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 37 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIR | 250,111 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2024-02-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL | 2024-02-22 | 2024-02-26 | $10.05 | $293K | -6.2% | -15.8% | -10.6% |
| VIR | SELL | 2024-02-16 | 2024-02-16 | $10.24 | $34K | +10.1% | +4.6% | -2.7% |
| VIR | SELL · 10b5-1 | 2023-06-07 | 2023-06-08 | $25.95 | $130K | -4.0% | -9.8% | -53.5% |
| VIR | SELL | 2023-02-27 | 2023-02-28 | $23.08 | $238K | -0.4% | +1.4% | +14.4% |
| VIR | SELL | 2023-02-23 | 2023-02-24 | $25.97 | $149K | -0.4% | +1.1% | +13.3% |
| VIR | SELL | 2023-02-17 | 2023-02-21 | $25.29 | $142K | -15.4% | -17.6% | -4.7% |
| VIR | SELL | 2023-01-24 | 2023-01-25 | $30.00 | $900K | -4.1% | -26.0% | -19.7% |
| VIR | SELL | 2022-07-20 | 2022-07-21 | $30.00 | $150K | -6.9% | -19.0% | -31.7% |
| VIR | SELL | 2022-06-21 | 2022-06-22 | $24.89 | $248K | +12.5% | +17.2% | -22.3% |
| VIR | SELL | 2022-02-16 | 2022-02-18 | $31.75 | $350K | -17.6% | -14.1% | -15.5% |
| VIR | SELL | 2022-02-02 | 2022-02-04 | $34.52 | $345K | -0.8% | -32.3% | -37.2% |
| VIR | SELL | 2022-01-19 | 2022-01-20 | $35.06 | $351K | +8.6% | -9.0% | -29.3% |
| VIR | SELL | 2022-01-05 | 2022-01-06 | $37.19 | $186K | +0.4% | +1.7% | -34.1% |
| VIR | SELL | 2021-12-15 | 2021-12-17 | $50.51 | $391K | -30.0% | -38.4% | -56.7% |
| VIR | SELL | 2021-12-01 | 2021-12-03 | $43.45 | $517K | +21.3% | -7.4% | -42.9% |
| VIR | SELL | 2021-11-17 | 2021-11-19 | $35.80 | $341K | +41.8% | +57.9% | -4.5% |
| VIR | SELL | 2021-11-03 | 2021-11-04 | $36.47 | $182K | -1.0% | +13.7% | -2.2% |
| VIR | SELL | 2021-10-20 | 2021-10-22 | $39.65 | $159K | -10.0% | -22.7% | -18.9% |
| VIR | SELL | 2021-10-06 | 2021-10-07 | $34.56 | $173K | +17.6% | -5.1% | -1.2% |
| VIR | SELL | 2021-09-15 | 2021-09-17 | $49.64 | $461K | -19.6% | -27.7% | +0.7% |
| VIR | SELL | 2021-09-01 | 2021-09-02 | $49.60 | $446K | +4.9% | -31.7% | -5.8% |
| VIR | SELL | 2021-08-18 | 2021-08-20 | $42.23 | $422K | -0.3% | +4.4% | -33.5% |
| VIR | SELL | 2021-08-04 | 2021-08-05 | $34.92 | $175K | +4.6% | +24.2% | -8.0% |
| VIR | SELL | 2021-07-21 | 2021-07-23 | $37.44 | $347K | +0.5% | +30.2% | +8.2% |
| VIR | SELL | 2021-07-07 | 2021-07-08 | $40.38 | $404K | -2.3% | +2.8% | -14.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.